Profil
Satu Vainikka was the founder and had founded Cronos Therapeutics Ltd. in 2004, where she held the title of Chief Executive Officer & Director until 2006.
She has also held former positions as Chief Executive Officer at ValiRx Plc in 2020, Director at Cronos Therapeutics Ltd. from 2009 to 2020, and Independent Non-Executive Director at VolitionRX Ltd. from 2012 to 2013.
Dr. Vainikka has an MBA from Imperial College London in 2000 and a doctorate from the University of Helsinki in 1996.
Ehemalige bekannte Positionen von Satu Vainikka
| Unternehmen | Position | Ende |
|---|---|---|
| VALIRX PLC | Vorstandsvorsitzender | 08.06.2020 |
Cronos Therapeutics Ltd.
Cronos Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Direktor/Vorstandsmitglied | 29.04.2020 |
| VOLITIONRX LIMITED | Direktor/Vorstandsmitglied | 15.05.2013 |
Cronos Therapeutics Ltd.
Cronos Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Gründer | 01.01.2006 |
Ausbildung von Satu Vainikka
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
ValiRx Plc
ValiRx Plc Pharmaceuticals: MajorHealth Technology Develops novel technologies and products in oncology therapeutics and diagnostics | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cronos Therapeutics Ltd.
Cronos Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
VolitionRX Ltd.
VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
















